Eli Lilly (LLY) Gross Margin (2009 - 2026)
Eli Lilly's Gross Margin came in at 83.88% for Q3 2026, up 0.97 percentage points from 82.91% a year earlier but down 1.90 percentage points from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) Gross Margin (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Eli Lilly reported Gross Margin of 83.63%, up 0.61 percentage points year-over-year; for FY2025, it was 83.04%, up 1.73 percentage points from FY2024.
- Gross Margin has increased in each of the last four years, with a five-year change of +5.39 percentage points (FY2020 to FY2025).
- Going back by year, Gross Margin was 81.31% in FY2024 (+2.06 pp), 79.25% in FY2023 (+2.47 pp), 76.77% in FY2022 (+2.59 pp) and 74.18% in FY2021 (-3.48 pp).
- The five-year range for quarterly Gross Margin is 73.47% (Q1 2022) to 85.78% (Q2 2026).
- Year-over-year, Gross Margin increased in seven of the last eight quarters, with an average year-over-year change of +1.31 percentage points.
- The fastest year-over-year change in Gross Margin over five years came in Q2 2022 (a gain of 6.93 percentage points), and the weakest in Q4 2021 (a drop of 2.51 percentage points).
- Business Quant data shows LLY's Gross Margin at 85.78% (Q2 2026), 81.93% (Q1 2026) and 82.52% (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 75.71% |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 84.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 83.88% |
| Jun 30, 2026 | 85.78% |
| Mar 31, 2026 | 81.93% |
| Dec 31, 2025 | 82.52% |
| Sep 30, 2025 | 82.91% |
| Jun 30, 2025 | 84.27% |
| Mar 31, 2025 | 82.52% |
| Dec 31, 2024 | 82.24% |
| Sep 30, 2024 | 81.02% |
| Jun 30, 2024 | 80.80% |
| Mar 31, 2024 | 80.91% |
| Dec 31, 2023 | 80.89% |
| Sep 30, 2023 | 80.42% |
| Jun 30, 2023 | 78.26% |
| Mar 31, 2023 | 76.63% |
| Dec 31, 2022 | 78.80% |
| Sep 30, 2022 | 77.25% |
| Jun 30, 2022 | 77.95% |
| Mar 31, 2022 | 73.47% |
| Dec 31, 2021 | 74.37% |
API Access
Eli Lilly Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();